Prot# CST1571BUS129: Phase I/II Study of Gleevec (Imatinib Mesylate, formerly known as STI571) and Gemcitabine for Advanced Pancreas Cancer (NU Prot# NU 02 I8)

Project: Research project

Project Details

StatusFinished
Effective start/end date12/15/02 → 12/14/04

Funding

  • Novartis Pharmaceuticals Corporation (CST1571BUS129)